Researchers studying century-old drug in potential new approach to autism

(University of California - San Diego) In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news